RVU Relative Valuation - Ryvu Therapeutics SA - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 51.9 PLN 0.78% Market Closed
Market Cap: 1.2B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Relative Value

The Relative Value of one RVU stock under the Base Case scenario is 13.32 PLN. Compared to the current market price of 51.9 PLN, Ryvu Therapeutics SA is Overvalued by 74%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RVU Relative Value
Base Case
13.32 PLN
Overvaluation 74%
Relative Value
Price
R
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
10
Median 3Y
27.6
Median 5Y
50.9
Industry
3.8
Forward
4.3
vs History
vs Industry
Median 3Y
-13.2
Median 5Y
-13.2
Industry
30.8
Forward
-13.5
vs History
vs Industry
0
Median 3Y
-13.1
Median 5Y
-18.7
Industry
21.6
vs History
vs Industry
6
Median 3Y
-7.1
Median 5Y
-12.7
Industry
31.9
vs History
23
vs Industry
17
Median 3Y
5.3
Median 5Y
5.1
Industry
2.5
vs History
92
vs Industry
11
Median 3Y
22.4
Median 5Y
47
Industry
3.5
Forward
3.5
vs History
42
vs Industry
10
Median 3Y
30.2
Median 5Y
-23.6
Industry
7.8
vs History
vs Industry
Median 3Y
-12.4
Median 5Y
-16.7
Industry
19.1
Forward
-12.2
vs History
vs Industry
Median 3Y
-11
Median 5Y
-13.6
Industry
23
Forward
-10.6
vs History
vs Industry
1
Median 3Y
-10.9
Median 5Y
-17.2
Industry
20.1
vs History
vs Industry
7
Median 3Y
-6.8
Median 5Y
-12.5
Industry
27.6
vs History
71
vs Industry
15
Median 3Y
6.5
Median 5Y
6.6
Industry
2.2

Multiples Across Competitors

RVU Competitors Multiples
Ryvu Therapeutics SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
PL
Ryvu Therapeutics SA
WSE:RVU
1.2B PLN 21.6 -12.8 -10.7 -9.6
US
PerkinElmer Inc
LSE:0KHE
1.3T USD 475.7 7 604 1 618 3 503.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
233.5B USD 5.5 37.5 23.6 34.1
US
Danaher Corp
NYSE:DHR
192.7B USD 8.6 45.9 29.8 43.7
KR
Samsung Biologics Co Ltd
KRX:207940
68.7T KRW 16.3 66.8 35.9 51.4
CH
Lonza Group AG
SIX:LONN
38.7B CHF 5.8 67.5 45.6 45.6
US
IQVIA Holdings Inc
NYSE:IQV
44.3B USD 2.9 31.1 16.9 26.1
US
Agilent Technologies Inc
NYSE:A
39.4B USD 6.1 27.9 21.9 25.3
US
Mettler-Toledo International Inc
NYSE:MTD
29.2B USD 7.8 37.1 26.1 29.1
IE
ICON PLC
NASDAQ:ICLR
25.1B USD 3 35.1 16.3 24.9
US
West Pharmaceutical Services Inc
NYSE:WST
21.6B USD 7.5 41.1 28.3 35.1

See Also

Discover More
Back to Top